1.
Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study.
Vandewalle Evelien, Abegão Pinto Luís, Van Bergen Tine, Spielberg Leigh, Fieuws Steffen, Moons Lieve et al.
Br J OphthalmolJan 201456 citationsRandomized Controlled Trial
This study found intracameral bevacizumab with trabeculectomy significantly reduced the need for additional interventions (like needling) in glaucoma patients, improving absolute surgical success.